Past Speaking Engagements
05/3/10
Limerick BioPharma presented an abstract (#306) which was showcased at a poster session on May 3, 2010 in the “Novel Agents in Kidney Transplant Immunosuppression” session at the American Transplant Congress in San Diego, CA.
05/2/10
Wendye Robbins, MD, President and CEO of Limerick BioPharma, provided an oral presentation of 4 Limerick abstracts in the “Novel Renal Allograft Immunosuppression” platform on May 2, 2010, at American Transplant Congress in San Diego, CA.
04/15/10
Michael Chang, PhD, VP of Research and Development of Limerick BioPharma, served as a panel expert on the topic of “Effective Outsourcing: Navigating Hurdles and Avoiding Pitfalls in Virtual Drug Development” at the All About Science Series on April 15, 2010 in San Jose, CA.
02/5/10
Wendye Robbins, MD, President and CEO of Limerick BioPharma, presented “Career Management Strategies” at KGI’s Smith College’s Next Generation Bioscience Leaders Program on February 5, 2010 in Pomona, CA.
01/13/10
Wendye Robbins, MD, President and CEO of Limerick BioPharma, provided an overview of our immunosuppression and metabolic programs at the 2010 BioTech Showcase Conference on January 13, 2010 in San Francisco, CA.
10/22/09 and 10/26/09
Ving Lee, PhD, Sr. VP Research, presented at a Managed Outsourced Drug Discovery Seminar Series on October 22, 2009 at The Hilton Del Mar, Del Mar, CA and on October 26, 2009 at the Claremont Resort and Spa, Berkeley, CA. The topic was, “Outsourcing Drug Discovery Services from the Perspective of Both Sponsor and CRO”.
9/16/09
Wendye Robbins, MD, President and CEO, presented at the BioScience Forum on September 16, 2009 at The Clarion Hotel in Millbrae, CA. The topic was, “Turning the Paradigm Inside Out: Stimulating ABC Family Transporters to Protect Cells Against Disease and Drug Toxicity”.
4/15/09
Wendye Robbins, MD, President and CEO of Limerick BioPharma served as a panelist at the Bio E2E Conference. The topic of the conference was "Stimulating Your Startup: How to Successfully Start Your Company in Today’s Economy" that took place on April 15, 2009 at Wilson Sonsini Goodrich & Rosati in Palo Alto, CA.
3/15/09
Wendye Robbins, MD, President and CEO of Limerick BioPharma served as a panelist at the 2009 Women in Leadership Conference. The topic of the conference was "Evolving with the Changing Industry" that took place March 15, 2009 at the Haas School of Business, Berkeley, CA.
1/26/09
Wendye Robbins, MD, President and CEO of Limerick BioPharma presented "Unanticipated Risks of Opioid Therapy: Opioid-induced Sleep Disorders and Hyperalgesia" at the 7th Annual Pain Symposium that took place January 26-27, 2009 in Oahu, HI.
1/26/09
Sally Lam, PharMD, Director of Strategic Marketing of Limerick BioPharma presented "Unanticipated Risks of Opioid Therapy: Opioid-induced Endocrinopathy" at the 7th Annual Pain Symposium that took place January 26-27, 2009 in Oahu, HI.
10/29/08 - 10/31/08
Wendye Robbins, MD, President and CEO of Limerick BioPharma, provided an overview of our immunosuppressive and opioid programs at the 2008 BIO Investor Forum that took place October 29-31, 2008 in San Francisco, CA.
09/23/08
Ving Lee, PhD, Sr. Vice President of Research of Limerick BioPharma, presented "The Path to New Drugs, While Tedious, Provides New Scientific and Business Opportunities" at the San Jose BioCenter.
08/19/08
Limerick’s Phase I study on Opioid-induced Hypogonadism was presented at the International Association for the Study of Pain. Scotland, UK.
06/22/08
Limerick BioPharma presented at the Gordon Research on Barriers of the CNS Conference. Tilton, New Hampshire.
06/17/08
Wendye Robbins, MD, President and CEO of Limerick BioPharma provided an overview of our immunosuppressive and opioid programs at the 2008 BIO International Convention. San Diego, CA.
05/09/08
Wendye Robbins, MD, President and CEO of Limerick BioPharma participated in a panel on "Drug Delivery and the Blood Brain Barrier" at The Neurotech Investing and Partnering Conference. Boston, MA
04/01/08
Limerick BioPharma presented results from recent clinical trial at the 28th Annual Meeting of the Australian Pain Society. Perth, Australia.
12/12/07
Wendye Robbins, MD, President and CEO of Limerick BioPharma presented at the 2007 RBC Capital Markets Healthcare Conference. New York City, NY.
11/28/07
Ving Lee, PhD, Sr. Vice President of Research of Limerick BioPharma, presented "Natural Product-Based Therapeutics -- Their Biological and Chemistry Challenges" at Purdue University Department of Chemistry. This was part of a Semester Series on Medicinal Chemistry and Chemistry from Industrial to Biotech Perspectives. West Lafayette, IN.
10/10/07
Wendye Robbins, MD, President and CEO of Limerick BioPharma provided an overview of our immunosuppressive and opioid programs at the 2007 BIO Investor Forum. San Francisco, CA.
